NCT00621036 2018-11-26Vaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaUniversity of Texas Southwestern Medical CenterPhase 2 Withdrawn
NCT02520102 2017-04-20Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous LeukemiaSanofiPhase 2 Withdrawn
NCT00446173 2015-08-25Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaM.D. Anderson Cancer CenterPhase 2 Withdrawn